https://www.selleckchem.com/pr....oducts/Semagacestat(
Early-onset coronary artery disease (EOCAD) increases the risk of major cardiac adverse events (MACE) at the level of safety/effectiveness-related events. Since adverse events affect the quality of life of young patients with EOCAD, MACE prediction is of great importance for improving medical decision-making. We sought to determine whether the most important inflammation-related microRNAs in atherogenesis could predict MACE among patients with EOCAD. This nested case-control study recruited 143 young patients (males ≤45 a
Like
Comment
Share
